Postural orthostatic tachycardia syndrome (POTS) is generally classified into three main subtypes: neuropathic, hyperadrenergic, and hypovolemic. These categories describe the primary mechanism driving the abnormal heart rate increase that defines the condition. In practice, many people have overlapping features from more than one subtype, but understanding which type dominates can shape treatment decisions and help explain why symptoms vary so much from person to person.
POTS is diagnosed when your heart rate rises by at least 30 beats per minute within 10 minutes of standing (40 bpm for adolescents), without a significant drop in blood pressure. It disproportionately affects women, who make up roughly 84% to 91% of patients in large studies, and onset typically occurs between the late teens and mid-40s.
Neuropathic POTS
Neuropathic POTS is the most commonly identified subtype. The underlying problem is damage to small nerve fibers, particularly those that control blood vessel constriction in the legs and abdomen. When you stand, gravity pulls blood downward. Normally, nerves signal those lower blood vessels to tighten, pushing blood back up toward your heart and brain. In neuropathic POTS, that signal is weak or absent, so blood pools in the legs. Your heart compensates by beating faster.
Studies comparing skin biopsies from POTS patients and healthy controls have found that people with this subtype have a lower density of small nerve fibers in the lower legs. This is the same type of nerve damage seen in small fiber neuropathy, and it explains why many people with neuropathic POTS also experience burning, tingling, or numbness in their feet. Conditions that damage small nerves, including diabetes, autoimmune diseases like Sjögren’s syndrome and lupus, and celiac disease, can all trigger this form of POTS.
Hyperadrenergic POTS
A smaller subset of patients has a primary problem of excessive adrenaline-like activity. In hyperadrenergic POTS, standing triggers a surge of norepinephrine (the body’s main “fight or flight” chemical for blood vessel control) that goes far beyond what the situation calls for. Levels of norepinephrine in the blood upon standing can exceed 1,000 picograms per milliliter, sometimes climbing above 2,000, when the normal upper limit is around 475.
This flood of stimulation drives the heart rate up but also produces a distinct symptom profile. Unlike other subtypes, hyperadrenergic POTS often causes blood pressure to rise on standing rather than staying flat or dropping. People with this type frequently report intense tremor, anxiety, and a pounding heartbeat that feels out of proportion to what they’re doing. Migraine-like headaches and facial flushing are also common. The baroreflexes, which normally buffer sudden blood pressure changes, appear to be impaired in this group, which is why the body overshoots rather than self-correcting.
Identifying this subtype matters because treatments that expand blood volume, like IV saline, need to be used cautiously. Increasing fluid volume in someone whose blood pressure already spikes on standing can worsen symptoms.
Hypovolemic POTS
In hypovolemic POTS, the central issue is that your body simply doesn’t have enough blood volume. Research published in Circulation found that POTS patients had an average plasma volume deficit of about 13%, with some individuals missing more than 20% of their expected volume. Less blood in the system means less blood returning to the heart when you stand, forcing the heart to speed up to maintain circulation.
What makes this subtype puzzling is that the body’s normal volume-recovery system doesn’t kick in the way it should. When blood volume drops, the kidneys are supposed to activate a hormonal chain (the renin-angiotensin-aldosterone system) that tells the body to retain salt and water, gradually rebuilding volume. In hypovolemic POTS, that response is paradoxically flat. Renin activity stays unchanged and aldosterone levels remain low despite significant volume loss. Researchers have called this the “renin-aldosterone paradox.” Because the hormonal signal never arrives, the kidneys keep excreting salt and water as usual, and blood volume stays low.
This is the subtype where aggressive salt and fluid intake tends to be most directly helpful. Some patients also benefit from periodic IV saline infusions, typically one liter over one to two hours on a weekly basis, adjusted up or down based on response.
Overlap and Secondary POTS
These three subtypes are not mutually exclusive. A person can have nerve damage that causes blood pooling and low blood volume at the same time, or nerve damage that triggers a compensatory adrenaline surge. The subtypes describe dominant mechanisms, not rigid categories, and many clinicians find that their patients don’t fit neatly into one box.
POTS can also be classified as primary (arising on its own) or secondary (triggered by another condition). Common secondary causes include autoimmune diseases like Sjögren’s syndrome, lupus, and celiac disease. Connective tissue disorders are another significant overlap: studies have found that 15% to 31% of people diagnosed with POTS also meet the criteria for hypermobile Ehlers-Danlos syndrome, a condition that affects the flexibility and integrity of connective tissue throughout the body. Viral infections, including COVID-19, are increasingly recognized as triggers. In studies of long COVID patients, POTS diagnosis rates are notably elevated, particularly among younger women.
Autoimmune Features Across Subtypes
There is growing interest in whether some cases of POTS are fundamentally autoimmune, regardless of which subtype they resemble on the surface. Researchers have identified antibodies that target receptors involved in heart rate regulation and blood vessel control. These antibodies can, in laboratory settings, activate immune cells and trigger mast cell degranulation (the release of histamine and other inflammatory chemicals), which could explain why so many POTS patients also deal with flushing, hives, and GI symptoms.
However, these same antibodies also appear in healthy people, and they’ve been found across a range of cardiovascular conditions. Whether they’re a cause of POTS, a consequence of it, or simply a marker of cardiovascular stress remains an open question. For now, “autoimmune POTS” is not a formally recognized subtype, but it’s a framework that many patients and clinicians find useful when standard treatments aren’t working.
How Subtype Affects Treatment
All subtypes benefit from increased fluid and salt intake, compression garments (especially waist-high), and a structured exercise program. But emphasis shifts depending on what’s driving the tachycardia.
- Neuropathic POTS responds well to compression that counteracts lower-body blood pooling, along with medications that help blood vessels constrict. Treating the underlying cause of nerve damage, when one is identified, can also improve symptoms over time.
- Hyperadrenergic POTS is often managed with medications that dial down the overactive adrenaline response. Volume expansion needs to be approached carefully because of the tendency toward blood pressure spikes.
- Hypovolemic POTS benefits most directly from volume-building strategies: high salt intake (often 8 to 10 grams per day), two to three liters of fluid daily, and in some cases IV saline infusions.
The Role of Exercise Rehabilitation
One of the most effective long-term interventions for all POTS subtypes is a graduated exercise program. The most widely used protocol, developed at Children’s Hospital of Philadelphia and based on earlier work at UT Southwestern, follows a careful progression designed to avoid the symptom flares that upright exercise typically causes in POTS.
For the first three months, all cardio work is done in a recumbent or seated position: recumbent bikes, rowing machines, swimming, or seated steppers. This allows the cardiovascular system to build endurance without fighting gravity. Strength training focuses on the lower body and core, using body weight or seated machines, with three sets of 8 to 10 repetitions. Heart rate monitoring is essential during this phase to keep effort in the right zone.
Around month four, you transition to an upright bike. By month five, elliptical machines and treadmill walking are introduced. Months six through eight bring high-intensity interval training and full upright exercise with arm motion and treadmill incline. Recovery days, where you stay active but keep your heart rate low, are built in after every hard workout. The full protocol spans roughly eight months, and skipping the early recumbent phase is one of the most common reasons people struggle with it.